Joseph Pitts actually said...
Despite the success of Accelerated Approval for cancer drugs, I have talked with patients and innovators and investors, and they indicate that some in FDA intend to limit the use of the Accelerated Approval pathway for cancer drugs.
Context
Pitts expresses concern over potential limitations on Accelerated Approval for cancer drugs.
03/07/2012